Nabumetone Tablet
Product Images NDC 67296-2137

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 67296-2137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

This text provides information regarding a medication called Nabumetone, USP 500 mg tablets. It includes the National Drug Code (NDC) for this medication as 5028-465-01. The text also mentions the usual dosage of Nabumetone. Additionally, it advises to dispense the medication in its original container and emphasizes keeping it out of the reach of children. The text further includes details about the manufacturer or distributor located in Hauppauge, NY 11785.*

FDA Label Image

Container2 (Container2)

FDA Label Image

Container2 (Container3)

The text provides information about a medication called nabumetone. Each tablet contains 750 mg of nabumetone USP, with a National Drug Code (NDC) of 50228-466-01. The usual dosage and storage instructions are mentioned for nabumetone tablets. The medication is to be dispensed in a light-resistant container and must be kept at controlled room temperature. The accompanying Medication Guide should be dispensed to each patient, and the tablets are for prescription use only. The manufacturer is identified as Ascend Laboratories, located in Hauppauge, NY 11788.*

FDA Label Image

Container2 (Container4)

This text provides information on a medication called nabumetone, with each tablet containing 750 mg of the active ingredient. It instructs to store the tablets at a temperature range of 20°C to 25°C and dispense them in a tight, light-resistant container with a child-resistant closure. The manufacturer is listed as ScieGien Pharmaceuticals, Inc. with an address in Hauppauge, NY. The text also mentions to keep the medication out of reach of children and dispense the accompanying Medication Guide to each patient.*

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

This text provides the chemical structure COOH followed by another chemical structure CHgO that appear to be formula representations. The text also mentions "6-methoxy-2-naphthylacetic acid (SMNA)", which seems to be the name of a specific chemical compound. It likely is a detailed identification of a particular organic compound.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.